Please assess the completion status of the following clinical trial:

Trial Title: Donor Stem Cell Transplant After Conditioning Therapy in Treating Patients With Hematologic Cancer, Recurrent or Metastatic Solid Tumor, or Other Disease

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: None

Eligibility Criteria:
DISEASE CHARACTERISTICS:~* Diagnosis of 1 of the following:~  * High-risk acute leukemia, including any of the following:~    * Refractory acute leukemia~   * Acute leukemia beyond first remission~   * Acute leukemia in first remission with poor prognostic features (e.g., chromosomal changes suggesting poor prognosis)~ * Chronic myelogenous leukemia in second chronic, accelerated, or blastic phase~ * Severe aplastic anemia that is not responsive to immunosuppressive therapy~ * Myelodysplastic syndromes, including any of the following:~    * Refractory anemia (RA) or RA with ringed sideroblasts with severe cytopenia~   * RA with excess blasts (RAEB)~   * RAEB in transformation~   * Chronic myelomonocytic leukemia~ * Refractory or relapsed non-Hodgkin or Hodgkin lymphoma~ * Multiple myeloma~ * Biopsy proven measurable solid tumor meeting 1 of the following criteria:~    * Recurrent disease after primary treatment and deemed incurable to standard treatment~   * Metastatic disease for which no known standard therapy that is potentially curative or definitely capable of extending life expectancy exists~* Must have a related HLA-haploidentical mismatched (3/6 or fewer loci) donor available~PATIENT CHARACTERISTICS:~* Karnofsky performance status 70-100%~* Bilirubin \< 2.0 mg/dL~* AST \< 3 times upper limit of normal~* Creatinine \< 2.0 mg/dL~* Ejection fraction \> 40% by MUGA~PRIOR CONCURRENT THERAPY:~* See Disease Characteristics

- Gender: ALL
- Minimum Age: None
- Maximum Age: 65 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).